Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
asklepios biopharmaceutical
bioeurope
biogen
biomarin pharmaceutical
biotech
biotechnology
blood
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer
cara therapeutics
coronavirus
deerfield management
detroit blog main
detroit top stories
drug development
drug discovery
esperion
europe blog main
europe top stories
fda
financing
gilead sciences
immunomedics
incyte
indiana blog main
indiana top stories
ipo
kite
korsuva
lantern pharma
laura shawver
What
covid
2
×
isn’t
2
×
new
work
2
×
according
activity
approvals
aren’t
bio
biogen
blood
cases
charged
china
clamped
concept
convalescent
delays
developing
donation
drugs
economic
fast
fda
fight
help
including
ipo
known
lot
medicines
oric’s
patients
people
plasma
recover
recovered
roundup
serum
severe
Language
unset
Current search:
isn’t
×
covid
×
work
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@technologyreview.com
4 years ago
Blood plasma taken from covid-19 survivors might help patients fight it off
